Novartis

Latest stories

56m
Pilipino Star
A talk about issues on kidney diseaselaunched the Renal Gift Allowing Life for Others (REGALO) organ donation advoca
A talk about issues on kidney disease
Pilipino Star / Posted 56 minutes ago
launched the Renal Gift Allowing Life for Others (REGALO) organ donation advocacy. The groups have partnered with Novartis Healthcare Philippines. Uriarte said REGALO aims to increase the number of ESRD patients getting kidney transplants... Read more
12h
Daily Record
Shock figures show that Scotland's NHS spends £60m on private agency nurseslooked at the GP records of almost 15,000 heart failure patients with an averag
Shock figures show that Scotland's NHS spends £60m on private agency nurses
Daily Record / Posted 12 hours ago
looked at the GP records of almost 15,000 heart failure patients with an average age of 79. They found only 20 per cent were getting the right drug at the right dose. The study was funded by drug company Novartis and unveiled at a conference in R... Read more
21h
The Economic Times
Aurobindo, Intas in race for $1 billion buyout of Teva UK, submit binding offersfirm Cinven and buyout specialists Apollo Global Management LLC. A Bloomberg re
Aurobindo, Intas in race for $1 billion buyout of Teva UK, submit binding offers
The Economic Times / Posted 21 hours ago
firm Cinven and buyout specialists Apollo Global Management LLC. A Bloomberg report said global pharma giants Mylan NV and Novartis AG are also potential suitors but it could not be verified whether they had submitted firm bids last week. A buyer... Read more
1d
The Hindu
Thalassaemia patients worried about shortage of life-saving drugaccumulates due to frequent blood transfusion. If not taken regularly, the exce
Thalassaemia patients worried about shortage of life-saving drug
The Hindu / Posted yesterday
accumulates due to frequent blood transfusion. If not taken regularly, the excess iron will damage vital organs. While Novartis, the company that manufactures the drug, denies that there is any shortage, Thalassaemia Society of Karnataka... Read more
2d
Reuters
Stada shareholder AOC pushes through board reshufflein getting only one of its candidates voted onto the board on Friday, Eric Corn
Stada shareholder AOC pushes through board reshuffle
Reuters / Posted 2 days ago
in getting only one of its candidates voted onto the board on Friday, Eric Cornut, a former manager at Swiss drugmaker Novartis (NOVN.S), and said it was now looking into legal measures to challenge the second-round run-off election of board... Read more
3d
Morningstar
One-Stop Shopping for Exposure to International Stockswith global operations. Top holdings include names such as Nestle , Toyota Mo
One-Stop Shopping for Exposure to International Stocks
Morningstar / Posted 3 days ago
with global operations. Top holdings include names such as Nestle , Toyota Motor , and pharmaceuticals Roche , and Novartis . The fund excludes small-cap companies, so its holdings tend to have a larger average market capitalization than... Read more
3 related stories
4d
University of Pennsylvania Health System
Penn Medicine's Carl June, MD, Receives Novartis Immunology Award for Cancer Cell Therapy DevelopmentUniversity of Pennsylvania and director of Translational Research in Penn’s Abr
Penn Medicine's Carl June, MD, Receives Novartis Immunology Award for Cancer Cell Therapy Development
University of Pennsylvania Health System / Posted 4 days ago
University of Pennsylvania and director of Translational Research in Penn’s Abramson Cancer Center, has been awarded a 2016 Novartis Prize for Clinical Immunotherapy for his work developing personalized cellular therapies for cancer using Chimeric... Read more
4d
USA Today
A timeline of eye-popping drug priceschronic myeloid leukemia from a death sentence into a chronic disease, cost $31
A timeline of eye-popping drug prices
USA Today / Posted 4 days ago
chronic myeloid leukemia from a death sentence into a chronic disease, cost $31,488 a year when it was approved. Novartis has since tripled the cost to more than $110,000 — even though Gleevec now competes with two similar drugs.January... Read more
4d
The Economic Times
Former Wipro top executive Sangita Singh may join Infosysdevices and life sciences spaces. She had direct oversight of some of Wipro's t
Former Wipro top executive Sangita Singh may join Infosys
The Economic Times / Posted 4 days ago
devices and life sciences spaces. She had direct oversight of some of Wipro's top accounts such as Johnson & Johnson, Novartis, Astra Zeneca and Takeda. Some two years ago, under Singh's leadership, Wipro signed a $400-million deal with... Read more
4d
The Economic Times
Former Wipro top executive Sangita Singh may join Infosysdevices and life sciences spaces. She had direct oversight of some of Wipro's t
Former Wipro top executive Sangita Singh may join Infosys
The Economic Times / Posted 4 days ago
devices and life sciences spaces. She had direct oversight of some of Wipro's top accounts such as Johnson & Johnson, Novartis, Astra Zeneca and Takeda. Some two years ago, under Singh's leadership, Wipro signed a $400-million deal with... Read more
4d
Daily Record
Water workouts, fitness on Lake Hopatcongyourself and propel your body forward,” said Karpiak, a slender blonde who mana
Water workouts, fitness on Lake Hopatcong
Daily Record / Posted 4 days ago
yourself and propel your body forward,” said Karpiak, a slender blonde who manages clinical trials in the oncology group at Novartis. “The balance wasn’t as difficult for me as for some people. I chose weekdays when the water’s calm. I kind of eased... Read more
4d
WWLP Springfield
Snapshot reveals growth in healthy Bay State biopharma sectorindustry jobs. The average salary was $147,432. The state’s largest biopharma
Snapshot reveals growth in healthy Bay State biopharma sector
WWLP Springfield / Posted 4 days ago
industry jobs. The average salary was $147,432. The state’s largest biopharma employers are Sanofi Genzyme, Biogen, Shire, Novartis, Takeda, Pfizer, Parexel International, Quest Diagnostics, Vertex, Charles River Laboratories and EMD Millipore,... Read more
4d
Fortune
Here's Why Mylan Has Something to Be Happy About Todayto Bloomberg, Teva has roughly 80% of its patients on that dosage, as cheaper g
Here's Why Mylan Has Something to Be Happy About Today
Fortune / Posted 4 days ago
to Bloomberg, Teva has roughly 80% of its patients on that dosage, as cheaper generic versions of the drug from Novartis and Momenta using a lower dosage on a daily basis, are also pressuring sales. For Mylan, the news is likely a... Read more
4d
FOX Business
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higherfor Teva, but it's a large company, so the damage isn't as severe as the benefi
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
FOX Business / Posted 4 days ago
for Teva, but it's a large company, so the damage isn't as severe as the benefit to Momenta. Shares of Momenta's partner Novartis(NYSE: NVS), which will sell the drug, hardly moved on the news, which isn't too surprising given how large a... Read more
4d
FOX Business
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Highercompany, so the damage isn't as severe as the benefit to Momenta. Continue Rea
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
FOX Business / Posted 4 days ago
company, so the damage isn't as severe as the benefit to Momenta. Continue Reading Below Shares of Momenta's partner Novartis(NYSE: NVS), which will sell the drug, hardly moved on the news, which isn't too surprising given how large a... Read more
5d
Boston Globe
Experimental cancer therapy holds great promise — but at great costwarn it’ll be years before it’s available to most patients who would stand to b
Experimental cancer therapy holds great promise — but at great cost
Boston Globe / Posted 5 days ago
warn it’ll be years before it’s available to most patients who would stand to benefit — even though two drug makers, Novartis AG and startup Kite Pharma Inc., are racing to get their versions of the therapy approved by regulators as early as... Read more
7d
Market Watch
Eli Lilly, AstraZeneca drug put on FDA fast trackhigh failure rate of research in Alzheimer's disease has led to other partnersh
Eli Lilly, AstraZeneca drug put on FDA fast track
Market Watch / Posted 7 days ago
high failure rate of research in Alzheimer's disease has led to other partnerships in the industry: last year Novartis AG struck a deal with Amgen Inc. An estimated 5.3 million Americans suffer from the disease, according to the... Read more
7d
Business Wire
Global Excimer & Femtosecond Ophthalmic Lasers Industry Analysis and Opportunity Assessment, 2016-2026Ambulatory Surgical Centers - Ophthalmology Clinics Companies Mentioned - Ab
Global Excimer & Femtosecond Ophthalmic Lasers Industry Analysis and Opportunity Assessment, 2016-2026
Business Wire / Posted 7 days ago
Ambulatory Surgical Centers - Ophthalmology Clinics Companies Mentioned - Abbott Medical Optics, Inc - Alcon Inc. (Novartis AG) - Bausch & Lomb Incorporated - iVIS Technologies - LENSAR, LLC. - NIDEK CO., LTD. - SCHWIND... Read more
7d
DW
US clears ChemChina's Syngenta takeover |a share. Syngenta was founded in the year 2000, following the merger of the ag
US clears ChemChina's Syngenta takeover |
DW / Posted 7 days ago
a share. Syngenta was founded in the year 2000, following the merger of the agricultural segments of pharmaceutical firms Novartis and AstraZeneca. Before accepting ChemChina's bid, the Swiss company had rejected an offer made by US-based rival... Read more
21 related stories
7d
Business Wire
Osteoporosis Companies Drugs (Merck, Sanofi, Novartis, Eli Lilly and Amgen) Sales & Forecast 2010Osteoporosis Companies Drugs (Merck, Sanofi, Novartis, Eli Lilly and Amgen) Sal
Osteoporosis Companies Drugs (Merck, Sanofi, Novartis, Eli Lilly and Amgen) Sales & Forecast 2010
Business Wire / Posted 7 days ago
Osteoporosis Companies Drugs (Merck, Sanofi, Novartis, Eli Lilly and Amgen) Sales & Forecast provides a comprehensive analysis of the current state of the market and likely future evolution over the next 5 years. This 21 page report with 12 Figures... Read more
8d
Times of Malta
Keeping dementia at bayin medicine. He held various posts in paediatrics in Malta and the UK, after wh
Keeping dementia at bay
Times of Malta / Posted 8 days ago
in medicine. He held various posts in paediatrics in Malta and the UK, after which he carried out clinical research for Novartis in Switzerland and Rhone Poulenc in Denmark and the UK. In 1990 he retired to Malta and took up activities related... Read more
8d
TheBull
The key stocks that moved this weekanother $US500 million to support its vast biotechnology operations after repor
The key stocks that moved this week
TheBull / Posted 8 days ago
another $US500 million to support its vast biotechnology operations after reporting a 10 per drop in annual profit as its Novartis influenza vaccines business continues to haemorrhage money. CWY - CLEANAWAY - up 18.5 cents, or 21.6 per cent, at... Read more
9d
The Economic Times
4 Ranbaxy execs quit as Sun Pharma wraps up rejigwas an old Ranbaxy hand. Subodh Deshmukh, who had joined Ranbaxy as senior VP-R
4 Ranbaxy execs quit as Sun Pharma wraps up rejig
The Economic Times / Posted 9 days ago
was an old Ranbaxy hand. Subodh Deshmukh, who had joined Ranbaxy as senior VP-R&D in 2013, has quit and joined Novartis as head, global development, India. Sun Pharma recently appointed Pradeep Sanghvi from Apotex as executive... Read more
10d
Business Wire
Kite Pharma Advisors and Scientific Pioneers in Cancer Immunotherapy Receive Prestigious Cellular Immune Therapy Awardkey advisors and scientific collaborators, both pioneers in the field of cancer
Kite Pharma Advisors and Scientific Pioneers in Cancer Immunotherapy Receive Prestigious Cellular Immune Therapy Award
Business Wire / Posted 10 days ago
key advisors and scientific collaborators, both pioneers in the field of cancer immunotherapy, have received the renowned Novartis Prize for Clinical Immunology. The winners were selected by an independent jury of seven world-class immunologists... Read more
10d
Boston Globe
CRISPR takes the wraps off joint venture with Bayerown research partnership with biotech Juno Therapeutics Inc. of Seattle, while
CRISPR takes the wraps off joint venture with Bayer
Boston Globe / Posted 10 days ago
own research partnership with biotech Juno Therapeutics Inc. of Seattle, while Intellia collaborates with Swiss drug giant Novartis AG, which also bases its global research operation in Cambridge. CRISPR itself struck an earlier alliance last fall... Read more
11d
WFMZ Eastern Pennsylvania and Western New Jersey
Arts Around Town: Henry 'The Fonz' Winkler to be featured guest at Wheels of Time – 'Ay!'from Regent University and a background in behavioral neuroscience from Lehigh
Arts Around Town: Henry 'The Fonz' Winkler to be featured guest at Wheels of Time – 'Ay!'
WFMZ Eastern Pennsylvania and Western New Jersey / Posted 11 days ago
from Regent University and a background in behavioral neuroscience from Lehigh University. She works full-time for Novartis Oncology, and is a professor of executive skills leadership in the MBA program at DeSales University in Center... Read more
11d
express
Breast cancer patients could be denied a treatment as officials deem it not cost effectivebe removed from the CDF list.Related articles The drug, also known as Afinitor
Breast cancer patients could be denied a treatment as officials deem it not cost effective
express / Posted 11 days ago
be removed from the CDF list.Related articles The drug, also known as Afinitor which is made by pharmaceutical company Novartis, is used for treating a specific type of advanced breast cancer. This is a huge blow to many breast cancer... Read more
11d
FOX Business
AbbVie Inc. vs. Eli Lilly & Co.for Lilly, its recently launched psoriasis treatment, Taltz, landed on the same
AbbVie Inc. vs. Eli Lilly & Co.
FOX Business / Posted 11 days ago
for Lilly, its recently launched psoriasis treatment, Taltz, landed on the same exclusion list, with Novartis' drug of the same class, Cosentyx, and Humira listed as preferred alternatives. Given the exclusion and increasingly... Read more
7 related stories
11d
FOX Business
AbbVie Inc. vs. Eli Lilly & Co.for Lilly, its recently launched psoriasis treatment, Taltz, landed on the same
AbbVie Inc. vs. Eli Lilly & Co.
FOX Business / Posted 11 days ago
for Lilly, its recently launched psoriasis treatment, Taltz, landed on the same exclusion list, with Novartis' drug of the same class, Cosentyx, and Humira listed as preferred alternatives. Given the exclusion and increasingly... Read more
7 related stories
12d
News-Medical-Net
Novartis Prizes for Immunology to be awarded to six scientists for groundbreaking researchToday Novartis announced that six scientists will receive the 2016 Novartis Pri
Novartis Prizes for Immunology to be awarded to six scientists for groundbreaking research
News-Medical-Net / Posted 12 days ago
Today Novartis announced that six scientists will receive the 2016 Novartis Prizes for Immunology at the upcoming 16th International Congress of Immunology (ICI) in Melbourne, Australia on Aug 22, 2016. The Novartis Prizes for Immunology are awarded... Read more
12d
FOX Business
Amgen Inc. vs. Biogenwhich is impressive but deeply troubling. Enbrel first earned FDA approval in 1
Amgen Inc. vs. Biogen
FOX Business / Posted 12 days ago
which is impressive but deeply troubling. Enbrel first earned FDA approval in 1998, and its main patent expired long ago.Novartisbrought U.S. competition several steps closer to market last month when an independent advisory panel voted... Read more
12d
FOX Business
Amgen Inc. vs. Biogenwhich is impressive but deeply troubling. Enbrel first earned FDA approval in 1
Amgen Inc. vs. Biogen
FOX Business / Posted 12 days ago
which is impressive but deeply troubling. Enbrel first earned FDA approval in 1998, and its main patent expired long ago.Novartisbrought U.S. competition several steps closer to market last month when an independent advisory panel voted... Read more
12d
Perth Now
CSL to hike spending after profit fallgrow its global operations after suffering a 10 per cent slide in profits due t
CSL to hike spending after profit fall
Perth Now / Posted 12 days ago
grow its global operations after suffering a 10 per cent slide in profits due to continuing losses on its recently acquired Novartis flu vaccines business. CSL - which has major facilities in Australia, Germany, Switzerland, UK and the US - on... Read more
4 related stories
12d
TheBull
Australian stocks open lowerand the earnings reports." CSL has posted a 10 per cent fall in annual net pro
Australian stocks open lower
TheBull / Posted 12 days ago
and the earnings reports." CSL has posted a 10 per cent fall in annual net profit, partly due to its acquisition of the Novartis influenza vaccines business. Its shares had fallen 6.14 per cent, or $7.165 to $109.59, at 1030 AEST. QBE's shares... Read more
14 related stories
12d
Adelaide Now
CSL to raise $US500m after mixed resultsmillion following the completion of its current $A1 billion buyback, which was
CSL to raise $US500m after mixed results
Adelaide Now / Posted 12 days ago
million following the completion of its current $A1 billion buyback, which was unveiled in October 2015. Mr Perreault said Novartis sales were lower than expected due to a mild flu season. Seqirus is forecast to book a loss in 2016/17, in line... Read more
4 related stories
12d
Herald Sun
CSL to raise $US500m after mixed resultsmillion following the completion of its current $A1 billion buyback, which was
CSL to raise $US500m after mixed results
Herald Sun / Posted 12 days ago
million following the completion of its current $A1 billion buyback, which was unveiled in October 2015. Mr Perreault said Novartis sales were lower than expected due to a mild flu season. Seqirus is forecast to book a loss in 2016/17, in line... Read more
4 related stories
12d
Weekly Times
CSL to raise $US500m after mixed resultsmillion following the completion of its current $A1 billion buyback, which was
CSL to raise $US500m after mixed results
Weekly Times / Posted 12 days ago
million following the completion of its current $A1 billion buyback, which was unveiled in October 2015. Mr Perreault said Novartis sales were lower than expected due to a mild flu season. Seqirus is forecast to book a loss in 2016/17, in line... Read more
4 related stories
12d
Australian Broadcasting Corporation
CSL profit dips 10pc to $1.2b in its centenary yearbillion ($1.6 billion). The slip in profit was partially due to integration of
CSL profit dips 10pc to $1.2b in its centenary year
Australian Broadcasting Corporation / Posted 12 days ago
billion ($1.6 billion). The slip in profit was partially due to integration of the recently acquired and underperforming Novartis influenza business as well as currency movements. On an underlying and constant currency basis — stripping out... Read more
12d
The Courier Mail
CSL flags $A500m buyback after profit fallshare buyback of around $A500 million after posting a 10 per cent fall in annua
CSL flags $A500m buyback after profit fall
The Courier Mail / Posted 12 days ago
share buyback of around $A500 million after posting a 10 per cent fall in annual net profit, hurt by its acquisition of the Novartis influenza vaccines business. The company booked net profit of $US1.24 billion ($A1.61 billion) for the year to June... Read more
4 related stories
13d
Business Wire
Carmot Therapeutics Appoints Aetna Wun Trombley, Ph.D. to the Board of Directors and Elena Viboch as Director of Business Development and OperationsOfficer of NGM Biopharmaceuticals. She joined NGM as head of Business Developme
Carmot Therapeutics Appoints Aetna Wun Trombley, Ph.D. to the Board of Directors and Elena Viboch as Director of Business Development and Operations
Business Wire / Posted 13 days ago
Officer of NGM Biopharmaceuticals. She joined NGM as head of Business Development in 2011. She was most recently from Novartis in Basel, Switzerland, where she was Chief of Staff for the Chief Executive Officer and worked on key corporate... Read more
13d
Swissinfo
Five reasons why Switzerland's top in innovationand they can provide valuable links between work being done in universities and
Five reasons why Switzerland's top in innovation
Swissinfo / Posted 13 days ago
and they can provide valuable links between work being done in universities and the industry. Pharma giants Roche and Novartis are based in Basel and belong to the top 20 companies in the world with the largest research budgets. A study... Read more
14d
Pasadena Star-News
Southern California biotech companies see potential in marijuanaa $10 copay from their insurance company. HURDLES TO OVERCOME Several hurdles
Southern California biotech companies see potential in marijuana
Pasadena Star-News / Posted 14 days ago
a $10 copay from their insurance company. HURDLES TO OVERCOME Several hurdles have kept pharma giants such as Pfizer or Novartis from developing major cannabis drugs. The federal government recently reaffirmed its ranking of marijuana alongside... Read more
15d
Orange County Register
Pharma seeks its piece of the pota $10 copay from their insurance company. HURDLES TO OVERCOME Several hurdles
Pharma seeks its piece of the pot
Orange County Register / Posted 15 days ago
a $10 copay from their insurance company. HURDLES TO OVERCOME Several hurdles have kept pharma giants such as Pfizer or Novartis from developing major cannabis drugs. The federal government recently reaffirmed its ranking of marijuana alongside... Read more
16d
The China Post
Novartis Korea executives charged over doctor bribes SEOUL--Prosecutors have indicted a former chief executive of the South Korean
Novartis Korea executives charged over doctor bribes
The China Post / Posted 16 days ago
SEOUL--Prosecutors have indicted a former chief executive of the South Korean unit of Novartis and five other former and current company managers over allegations that they illegally paid doctors... Read more
11 related stories
16d
FOX News
Novartis Korea executives charged with bribing doctorsSEOUL, South Korea – Prosecutors have indicted a former chief executive of the
Novartis Korea executives charged with bribing doctors
FOX News / Posted 16 days ago
SEOUL, South Korea – Prosecutors have indicted a former chief executive of the South Korean unit of Novartis and five other former and current company managers over allegations that they illegally paid doctors 2.6 billion won ($2.3 million) in return... Read more
11 related stories
16d
San Antonio Express-News
Novartis Korea executives charged with bribing doctorsA logo of Swiss pharmaceutical company Novartis is seen at the Novartis Korea o
Novartis Korea executives charged with bribing doctors
San Antonio Express-News / Posted 16 days ago
A logo of Swiss pharmaceutical company Novartis is seen at the Novartis Korea office in Seoul, South Korea, Saturday, Aug. 13, 2016. Prosecutors indicted the former chief executive of the South Korean unit of Novartis and five other former and... Read more
11 related stories
16d
Beaumont Enterprise
Novartis Korea executives charged with bribing doctorsA logo of Swiss pharmaceutical company Novartis is seen at the Novartis Korea o
Novartis Korea executives charged with bribing doctors
Beaumont Enterprise / Posted 16 days ago
A logo of Swiss pharmaceutical company Novartis is seen at the Novartis Korea office in Seoul, South Korea, Saturday, Aug. 13, 2016. Prosecutors indicted the former chief executive of the South Korean unit of Novartis and five other former and... Read more
11 related stories
16d
Chattanooga Times Free Press
Novartis Korea executives charged with bribing doctorsSEOUL, South Korea (AP) - Prosecutors indicted the former chief executive of th
Novartis Korea executives charged with bribing doctors
Chattanooga Times Free Press / Posted 16 days ago
SEOUL, South Korea (AP) - Prosecutors indicted the former chief executive of the South Korean unit of Novartis and five other former and current managers over allegations they illegally paid doctors 2.6 billion won ($2.3 million) in return for... Read more
11 related stories
16d
Salon.com
Novartis Korea executives charged with bribing doctorsSEOUL, South Korea (AP) — Prosecutors indicted the former chief executive of th
Novartis Korea executives charged with bribing doctors
Salon.com / Posted 16 days ago
SEOUL, South Korea (AP) — Prosecutors indicted the former chief executive of the South Korean unit of Novartis and five other former and current managers over allegations they illegally paid doctors 2.6 billion won ($2.3 million) in return for... Read more
11 related stories
16d
Island Packet
Novartis Korea executives charged with bribing doctorsProsecutors indicted the former chief executive of the South Korean unit of Nov
Novartis Korea executives charged with bribing doctors
Island Packet / Posted 16 days ago
Prosecutors indicted the former chief executive of the South Korean unit of Novartis and five other former and current managers over allegations they illegally paid doctors 2.6 billion won ($2.3 million) in return for prescribing the company's... Read more
11 related stories
More

People in this news